Results 211 to 220 of about 67,102 (251)
Incidence of adverse events in iron-deficient pregnant women and surgical patients undergoing intravenous iron treatment with ferric isomaltose or ferric carboxymaltose: A systematic review. [PDF]
Heger D +7 more
europepmc +1 more source
Some of the next articles are maybe not open access.
Related searches:
Related searches:
Nutrition Reviews, 2009
Parenteral iron is a useful and safe therapeutic measure to treat anaemia, and is a proven clinical alternative to blood transfusion. This review article summarises the main characteristics of the different formulations of parenteral iron, their advantages, indications, dosages and adverse effects.
Zoilo, Madrazo González +3 more
openaire +4 more sources
Parenteral iron is a useful and safe therapeutic measure to treat anaemia, and is a proven clinical alternative to blood transfusion. This review article summarises the main characteristics of the different formulations of parenteral iron, their advantages, indications, dosages and adverse effects.
Zoilo, Madrazo González +3 more
openaire +4 more sources
Update on intravenous iron choices
Current Opinion in Nephrology and Hypertension, 2014Iron deficiency is a major factor in the prevalence and severity of anemia in patients with chronic kidney disease (CKD). We review the pathophysiology impairing normal intestinal iron absorption in CKD and compare the characteristics of newer intravenous (i.v.) iron agents to the longstanding i.v.
Derek S, Larson, Daniel W, Coyne
openaire +2 more sources
Erythropoietin and intravenous iron in PBM
Transfusion and Apheresis Science, 2014The concept of patient blood management is such that if a patient with anemia can be identified in the pre-operative period, therapeutic modalities can be targeted to that patient who might benefit from such treatment. Management strategies include the optimization of preoperative hemoglobin by maximizing hemopoiesis and RBC mass.
openaire +2 more sources
Oral and Intravenous Iron Therapy
Pre-anemic iron deficiency and iron deficiency anemia are the most common health conditions. They are mostly caused by blood loss and/or inadequate dietary iron absorption and are managed with iron replacement therapy. The goal of iron replacement therapy is to correct anemia and replenish iron stores. In most patients, oral iron is typically the firstAndrea U, Steinbicker +1 more
openaire +2 more sources
Intravenous iron in patients with heart failure and iron deficiency: an updated meta-analysis
European Journal of Heart Failure, 2023Pierpaolo Pellicori +2 more
exaly

